Drug Shortage Report for MYLAN-LAMOTRIGINE

Last updated on 2021-01-12 History
Report ID 130881
Drug Identification Number 02265516
Brand name MYLAN-LAMOTRIGINE
Common or Proper name LAMOTRIGINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) LAMOTRIGINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BT
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-12-10
Estimated end date 2021-02-15
Actual end date
Shortage status Actual shortage
Updated date 2021-01-12
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-01-12 French Compare
v3 2021-01-12 English Compare
v2 2021-01-05 French Compare
v1 2021-01-05 English Compare